Venous thromboembolism prophylaxis may cause more harm than benefit: an evidence-based analysis of Canadian and international guidelines
Abstract A majority of deep vein thromboses identified in screening studies of hospitalized patients remain clinically insignificant. Guidelines based on these studies markedly overestimate the risk of clinical venous thromboembolism (VTE) and the benefit of heparin prophylaxis. Accordingly, in 2012...
Main Author: | Andrew Kotaska |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-10-01
|
Series: | Thrombosis Journal |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12959-018-0180-6 |
Similar Items
-
Extended Venous Thromboembolism Prophylaxis for High-Risk Patients Undergoing Surgery for Malignancy
by: A. Perre, et al.
Published: (2011-02-01) -
A cross-sectional, multicenter, observational study to assess the prophylaxis of venous thromboembolism in Lebanese and Jordanian hospitals
by: Imad Hajj, et al.
Published: (2021-02-01) -
Risk Factors, Prophylaxis, and Treatment of Venous Thromboembolism in Congenital Heart Disease Patients
by: Michael Silvey, et al.
Published: (2017-06-01) -
Evaluation of Drug Regimens Used for the Prophylaxis of Thromboembolic Events in a Referral Cancer Center in North of Iran
by: Saeed Dehkia, et al.
Published: (2017-03-01) -
Adherence to guideline of venous thromboembolism prophylaxis in a level 1 Trauma center in Thailand
by: Osaree Akaraborworn, et al.
Published: (2018-01-01)